Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ahrens, Ingo ^a,b   Domeij, Helena ^b   Topcic, Denijal ^b   Haviv, Izhak ^b   Merivirta, Ruusu Maaria ^b   Agrotis, Alexander ^c   Leitner, Ephraem ^b   Jowett, Jeremy B ^b   Bode, Christoph ^a   Lappas, Martha ^d   Peter, Karlheinz ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CD18 ANTIGEN; CD34 ANTIGEN; CD61 ANTIGEN; FIBRONECTIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; TRANSCRIPTOME;

ALPHA 2 MACROGLOBULIN GENE; ARTICLE; CD34+ HEMATOPOIETIC STEM CELL; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; COCULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE TECHNIQUE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GALECTIN 3 GENE; GDF15 GENE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LL 37 GENE; MICROARRAY ANALYSIS; PDK4 GENE; POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; UPREGULATION; ANGIOGENESIS; BLOOD; CELL CULTURE; CELL PROLIFERATION; CLONOGENIC ASSAY; CYTOLOGY; DNA MICROARRAY; FETUS BLOOD; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TIME;

ULEX;

ANTIGENS, CD34; CATHELICIDINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; ENDOTHELIAL CELLS; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TIME FACTORS; TRANSCRIPTOME;

EID: 80051611721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023210     Document Type: Article

References (51)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
2. Dimmeler S, (2010) Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol 30: 1088-1093.
3. Hirschi KK, Ingram DA, Yoder MC, (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1584-1595.
4. Hristov M, Erl W, Weber PC, (2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23: 1185-1189.
5. Jujo K, Ii M, Losordo DW, (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45: 530-544.
6. Rehman J, Li J, Orschell CM, March KL, (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
7. Kumar AH, Caplice NM, (2010) Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 30: 1080-1087.
8. Renault MA, Losordo DW, (2007) Therapeutic myocardial angiogenesis. Microvasc Res 74: 159-171.
9. Ott HC, Taylor DA, (2005) Circulating endothelial progenitor cells. N Engl J Med 353: 2613-2616; author reply 2613-2616.
10. Erbs S, Linke A, Adams V, Lenk K, Thiele H, et al. (2005) Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97: 756-762.
11. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, et al. (2009) From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 30: 890-899.
12. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
13. Yoder MC, (2009) Defining human endothelial progenitor cells. J Thromb Haemost 7 (Suppl 1): 49-52.
14. Arnaoutova I, George J, Kleinman HK, Benton G, (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12: 267-274.
15. Steinmetz M, Nickenig G, Werner N, (2011) Endothelial-regenerating cells: an expanding universe. Hypertension 55: 593-599.
16. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, et al. (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13: 87-102.
17. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699.
18. Wang XX, Zhang FR, Shang YP, Zhu JH, Xie XD, et al. (2007) Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 49: 1566-1571.
19. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
20. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
21. Bowman TV, Merchant AA, Goodell MA, (2007) Molecular profiling of hematopoietic stem cells. Methods Mol Med 134: 1-16.
22. Hahne F, Mehrle A, Arlt D, Poustka A, Wiemann S, et al. (2008) Extending pathways based on gene lists using InterPro domain signatures. BMC Bioinformatics 9: 3.
23. Raponi M, Belly RT, Karp JE, Lancet JE, Atkins D, et al. (2004) Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia. BMC Cancer 4: 56.
24. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
25. Yoder MC, (2010) Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 30: 1094-1103.
26. Hristov M, Weber C, (2009) Progenitor cell trafficking in the vascular wall. J Thromb Haemost 7 (Suppl 1): 31-34.
27. Redondo S, Hristov M, Gordillo-Moscoso AA, Ruiz E, Weber C, et al. (2008) High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population. J Immunol Methods 335: 21-27.
28. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, et al. (2006) Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 99: 315-322.
29. Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, et al. (2005) Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201: 63-72.
30. Ahrens IG, Moran N, Aylward K, Meade G, Moser M, et al. (2006) Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3). Exp Cell Res 312: 925-937.
31. Umemoto T, Yamato M, Shiratsuchi Y, Terasawa M, Yang J, et al. (2008) CD61 enriches long-term repopulating hematopoietic stem cells. Biochem Biophys Res Commun 365: 176-182.
32. Janic B, Guo AM, Iskander AS, Varma NR, Scicli AG, et al. (2010) Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 5: e9173.
33. O E, Lee BH, Ahn HY, Shin JC, Kim HK, et al. (2011) Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. FASEB J 25: 159-169.
34. Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, et al. (2010) Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics 3: 18.
35. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF, (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70: 953-963.
36. Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, et al. (2008) The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem 283: 30471-30481.
37. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
38. Pfosser A, El-Aouni C, Pfisterer I, Dietz M, Globisch F, et al. (2010) NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37. Stem Cells 28: 376-385.
39. Zhang Z, Shively JE, (2010) Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PLoS One 5: e13985.
40. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, et al. (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156: 899-909.
41. Neidhart M, Zaucke F, von Knoch R, Jungel A, Michel BA, et al. (2005) Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis 64: 419-424.
42. Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, et al. (2009) Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler Thromb Vasc Biol 29: 831-836.
43. Furuhata S, Ando K, Oki M, Aoki K, Ohnishi S, et al. (2007) Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis. Mol Cell Biochem 298: 125-138.
44. Yamagishi S, Matsui T, Nakamura K, (2009) Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders. Curr Pharm Des 15: 1027-1033.
45. Ago T, Sadoshima J, (2006) GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res 98: 294-297.
46. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, et al. (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98: 351-360.
47. Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, et al. (2008) Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 29: 2327-2335.
48. Taddei S, Virdis A, (2010) Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander? Eur Heart J 31: 1168-1171.
49. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, et al. (2011) GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nature medicine 17: 581-588.
50. Zhang Y, Ge G, Greenspan DS, (2006) Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin. J Biol Chem 281: 39096-39104.
51. Pula G, Mayr U, Evans C, Prokopi M, Vara DS, et al. (2009) Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Circ Res 104: 32-40.